Debates in type 1 diabetes – what is the future of technology and what is a “cure"? Part three of our interview with David Panzirer and Dana Ball.
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
39 readers recommended
Twitter summary: New Sanofi & MannKind partnership to bring inhaled insulin Afrezza to US in early 2015, presumably primarily to type 2 patients to start On August...
32 readers recommended
Twitter summary: Roche’s Lucentis granted “priority review” from FDA – decision by Feb. 2015, potentially 1 st ever eye medicine for diabetic retinopathy Roche recently...
43 readers recommended
Advances in type 1 diabetes at The American Diabetes Association 74th Scientific Sessions
36 readers recommended
Twitter summary: FDA approves first-ever SGLT-2 inhibitor/metformin combo pill in the US – Janssens’s Invokamet launched Aug 18 On August 8, Janssen announced the FDA...
28 readers recommended
Kicking off this weekend, what are we most excited about for this year’s ADA?
24 readers recommended
How a major research study is challenging an outdated FDA restriction.
52 readers recommended
What this dramatic movement in obesity therapy means for patients in Europe.
39 readers recommended
By Kelly Close Twitter Summary: @kellyclose speaks to @US_FDA in favor of PCSK9 inhibitor drug Praluent – need to bring more options to #PWD to fight against CV disease...
29 readers recommended
How this “disease interception” strategy could transform our knowledge of type 1 diabetes.
Harvard Stem Cell Lab Signs Two Major Partnerships to Bring Stem Cell Therapies for Diabetes to Life
34 readers recommended
Dr. Doug Melton and colleagues at the Harvard Stem Cell Institute recently announced new partnerships with Novartis and AstraZeneca to advance stem cell research for...
46 readers recommended
One of the biggest drug highlights at the 2015 ADA Scientific Sessions was a compelling presentation by diaTribe scientific Advisory Board member Dr. John Buse on brand...
52 readers recommended
First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?
42 readers recommended
Over seven million Americans have diabetic retinopathy – how Eylea provides another treatment for this serious complication.
22 readers recommended
How will a new drug fare in a 4,000-patient, four-year study?
26 readers recommended
Another diabetes drug that helps people lose weight?
32 readers recommended
Twitter summary: JAMA study shows that metformin is safest first-line therapy for type 2 diabetes – future GRADE study to show best second-line therapy The journal JAMA...
36 readers recommended
Current trial results show that obese patients using Contrave are about 41% less likely to experience any major heart event (e.g. heart attack, strokes, or heart-related...
42 readers recommended
After the rapid-acting inhaled insulin Afrezza launched this February, we have been very eager to learn more about how this new product impacts patients’ day-to-day...
38 readers recommended
ClinicalTrials.gov Identifier: NCT00920582 This study is currently recruiting patients recently diagnosed with type 1 diabetes to investigate the efficacy of teplizumab...